Austin Myeloma Round Table
Austin Myeloma Round Table
Event Description
Highlights
Why Stem Cells Matter - William Matsui, MD | MRT Austin, TX Mar 25, 2023
So Many Choices: Deciding Which Treatment is Best - Matthew Butler, MD | MRT Austin, TX Mar 25, 2023
Moving Novel Concepts Toward Front-Line Treatments - Hans Lee, MD | MRT Austin, TX Mar 25, 2023
Syed Abbas Ali Presents Case Studies: Discussion with Morning Faculty | MRT Austin, TX Mar 25, 2023
Round Table Audience Q&A Session One | MRT Austin, TX Mar 25, 2023
Extending Remission - Syed Abbas Ali, MBBS | MRT Austin, TX Mar 25, 2023
Full Faculty Group Discussion | MRT Austin, TX Mar 25, 2023
Why Stem Cells Matter - William Matsui, MD | MRT Austin, TX Mar 25, 2023
Round Table Audience Q&A Two | MRT Austin, TX Mar 25, 2023
Speakers & Moderators
William Matsui, MD, is Deputy Director of the LIVESTRONG Cancer Institutes, Professor in the Department Oncology and Director of Hematological Malignancies Program at the Dell Medical School at the University of Texas at Austin. He specializes in caring for patients with cancers that involve the blood and bone marrow as well as bone marrow transplantation. He came to Austin from the Johns Hopkins University School of Medicine, where he was a professor of oncology and served as the director of the Multiple Myeloma Program and the co-director of the Division of Hematologic Malignancies. Dr. Matsui has carried out laboratory-based translational research throughout his career and focused on studying cancer stem cells, tumor cells with enhanced growth potential and their role in clinical oncology. His laboratory first identified cancer stem cells in the plasma cell malignancy multiple myeloma in 2003 and subsequently in other cancers including lymphomas, leukemias and pancreas cancer. His laboratory has also demonstrated that several pathways regulating normal stem cells, including those involved in embryonic development, are abnormally activated in cancer stem cells. Dr. Matsui completed his residency training in internal medicine at the University of Washington in Seattle and his clinical training in medical oncology at Johns Hopkins. He earned his medical degree from the University of California at San Francisco.
Hans Lee, MD, is Assistant Professor in the Department of Lymphoma/Myeloma and Director of Multiple Myeloma Clinical Research at the MD Anderson Cancer Center in Houston, TX. Previously, Dr. Lee was the Chief Hematology Fellow at MD Anderson, where he previously held a Clinical Fellowship. He was a resident in Internal Medicine at the Washington University School of Medicine in St. Louis, MO after he earned his MD at the Indiana School of Medicine in Indianapolis, IN.
Dr. Syed Abbas Ali is a medical oncology specialist in Baltimore, caring for patients with cancer. Dr. Ali earned his M.B.B.S. at The Aga Khan University. He completed his residency at the University of Arkansas for Medical Sciences and performed a fellowship in medical oncology at the National Institutes of Health.
Dr. Matthew Butler is a faculty member of the division of hematology and oncology. Dr. Butler grew up in Nova Scotia, Canada, and worked in Toronto as a software developer before starting medical school. He completed his specialty training at UT Health San Antonio with a focus on blood cancers. His practice covers the full range of blood disorders, with a special interest in multiple myeloma. His clinical research focus is aimed at finding better treatments for malignant lymphomas
Location
Thompson Conference Center on the campus of the University of Texas
Joe C Thompson Conference Center, 2405 Robert Dedman Dr, Austin, TX 78712, USA
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
Get the latest thought leadership on your Multiple Myeloma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.